×
Phibro Animal Health Inventory 2012-2024 | PAHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Phibro Animal Health inventory from 2012 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
View More
Phibro Animal Health Inventory 2012-2024 | PAHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Phibro Animal Health inventory from 2012 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$202.6B
Stryker (SYK)
$144.4B
Boston Scientific (BSX)
$130.4B
Medtronic (MDT)
$113.2B
EssilorLuxottica (ESLOY)
$112.1B
Lonza Group Ag (LZAGY)
$45.3B
Haleon (HLN)
$43B
GE HealthCare Technologies (GEHC)
$39B
ResMed (RMD)
$36.5B
Terumo (TRUMY)
$30.6B
Koninklijke Philips (PHG)
$24.9B
Zimmer Biomet Holdings (ZBH)
$21.8B
Insulet (PODD)
$19.3B
Baxter (BAX)
$17.5B
Smith & Nephew SNATS (SNN)
$10.8B
Bio-Rad Laboratories (BIO)
$10.2B
BellRing Brands (BRBR)
$9.2B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$5.8B
TG Therapeutics (TGTX)
$4.8B
Haemonetics (HAE)
$4.6B
ICU Medical (ICUI)
$4.4B
Prestige Consumer Healthcare (PBH)
$4B
Perrigo (PRGO)
$3.6B
Envista Holdings (NVST)
$3.6B
Neogen (NEOG)
$3.6B
Agios Pharmaceuticals (AGIO)
$3.4B
GN Store Nord (GNNDY)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$2.9B